Q3 CY26 Quarterly Report 30 October 2026 A S X : O S X O S T E O P O R E . C O M Quarterly highlights Osteopore Limited (ASX:OSX) (“Osteopore” or the “Company”), a revenue-generating manufacturer of regenerative implants that empower natural tissue regeneration, is pleased to release its...
Activities Report September 2026 and Appendix 4C
Filed with ASX ·
6ix is reading this filing.
Story so far
Earlier from Osteopore
- OSX strikes orthopaedic deal for 5 Middle East countries
- Activities Report June 2026 and Appendix 4C
- OSX secures Hainan FDA approval for orthopaedic devices
- Activities Report March 2026 and Appendix 4C
- Further Drawdown of T2 of the Redeemable Convertible Notes
Follow Osteopore into a list and get an email when it puts out news.
Follow Osteopore